KATHERINE HOOSE: Open Payments
NPI 1720173339 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 40 payments from 15 companies in 2025. Trend: 2023 $1,327 · 2024 $1,191 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 3 | $149 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Novo Nordisk Inc | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Inspire Medical Systems, Inc. | 1 | $64 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| PFIZER INC. | 3 | $60 |
| Amgen Inc. | 3 | $54 |
Products named: EVKEEZA, LEQVIO, JARDIANCE, AMVUTTRA, Wegovy, FARXIGA, INSPIRE, ELIQUIS.
Industry payments across NY — which companies pay providers there.
